BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30033448)

  • 1. Angiopoietin-like protein 3 blocks nuclear import of FAK and contributes to sorafenib response.
    Bao Y; Yang F; Liu B; Zhao T; Xu Z; Xiong Y; Sun S; Qu L; Wang L
    Br J Cancer; 2018 Aug; 119(4):450-461. PubMed ID: 30033448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation.
    Zhao T; Liang X; Chen J; Bao Y; Wang A; Gan X; Lu X; Wang L
    Biochem Biophys Res Commun; 2019 Aug; 516(3):880-887. PubMed ID: 31270029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.
    Zhao T; Bao Y; Gan X; Wang J; Chen Q; Dai Z; Liu B; Wang A; Sun S; Yang F; Wang L
    Theranostics; 2019; 9(21):6175-6190. PubMed ID: 31534544
    [No Abstract]   [Full Text] [Related]  

  • 4. RASSF6-mediated inhibition of Mcl-1 through JNK activation improves the anti-tumor effects of sorafenib in renal cell carcinoma.
    Liang YY; Deng XB; Zeng LS; Lin XT; Shao XF; Wang B; Mo ZW; Yuan YW
    Cancer Lett; 2018 Sep; 432():75-83. PubMed ID: 29864454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma.
    Xu Z; Yang F; Wei D; Liu B; Chen C; Bao Y; Wu Z; Wu D; Tan H; Li J; Wang J; Liu J; Sun S; Qu L; Wang L
    Oncogene; 2017 Apr; 36(14):1965-1977. PubMed ID: 27841868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANGPTL3 Overexpression Suppresses the Development of Oncogenic Properties in Renal Cell Carcinoma via the Wnt/
    Zhang YJ; Zhang L; Feng F; Cao QF
    Dis Markers; 2021; 2021():2863856. PubMed ID: 34484467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma.
    Yuen JS; Sim MY; Sim HG; Chong TW; Lau WK; Cheng CW; Ong RW; Huynh H
    Int J Oncol; 2012 Aug; 41(2):712-20. PubMed ID: 22641227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
    Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
    Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
    Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
    PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
    Liu S; Gao M; Wang X; Ding S; Lv J; Gao D; Wang Z; Niu Z
    Oncotarget; 2016 Nov; 7(48):79141-79153. PubMed ID: 27816967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
    Gao X; Jiang P; Zhang Q; Liu Q; Jiang S; Liu L; Guo M; Cheng Q; Zheng J; Yao H
    J Exp Clin Cancer Res; 2019 Aug; 38(1):362. PubMed ID: 31426831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibitory effect of an injectable hyaluronic acid-tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells.
    Ueda K; Akiba J; Ogasawara S; Todoroki K; Nakayama M; Sumi A; Kusano H; Sanada S; Suekane S; Xu K; Bae KH; Kurisawa M; Igawa T; Yano H
    Acta Biomater; 2016 Jan; 29():103-111. PubMed ID: 26481041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma.
    He J; He J; Min L; He Y; Guan H; Wang J; Peng X
    Int J Cancer; 2020 Feb; 146(4):1052-1063. PubMed ID: 31259424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells.
    Yu X; Liu F; Zeng L; He F; Zhang R; Yan S; Zeng Z; Shu Y; Zhao C; Wu X; Lei J; Zhang W; Yang C; Wu K; Wu Y; An L; Huang S; Ji X; Gong C; Yuan C; Zhang L; Feng Y; Huang B; Liu W; Zhang B; Dai Z; Wang X; Liu B; Haydon RC; Luu HH; Gan H; He TC; Chen L
    Cell Physiol Biochem; 2018; 47(3):957-971. PubMed ID: 29843133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway.
    Liu L; Pang X; Shang W; Xie H; Feng Y; Feng G
    Cell Cycle; 2019 Feb; 18(3):257-263. PubMed ID: 29895198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.
    Yun EJ; Lin CJ; Dang A; Hernandez E; Guo J; Chen WM; Allison J; Kim N; Kapur P; Brugarolas J; Wu K; He D; Lai CH; Lin H; Saha D; Baek ST; Chen BPC; Hsieh JT
    Clin Cancer Res; 2019 Jul; 25(14):4542-4551. PubMed ID: 31000589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC).
    Kawazoe H; Bilim VN; Ugolkov AV; Yuuki K; Naito S; Nagaoka A; Kato T; Tomita Y
    Biochem Biophys Res Commun; 2012 Jul; 423(3):490-5. PubMed ID: 22683636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.